INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 132 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,238,000 | +11.2% | 101,665 | +4.1% | 0.00% | 0.0% |
Q4 2018 | $1,113,000 | -70.2% | 97,677 | -43.2% | 0.00% | 0.0% |
Q3 2018 | $3,730,000 | +59.3% | 171,924 | +29.8% | 0.00% | -50.0% |
Q2 2018 | $2,341,000 | -49.4% | 132,500 | -39.7% | 0.00% | -33.3% |
Q1 2018 | $4,624,000 | +82.9% | 219,673 | +25.8% | 0.00% | +50.0% |
Q4 2017 | $2,528,000 | +48.1% | 174,620 | +61.5% | 0.00% | +100.0% |
Q3 2017 | $1,707,000 | +23.9% | 108,156 | -2.5% | 0.00% | 0.0% |
Q2 2017 | $1,378,000 | -39.5% | 110,925 | -20.8% | 0.00% | -50.0% |
Q1 2017 | $2,276,000 | +6.0% | 140,080 | -1.5% | 0.00% | 0.0% |
Q4 2016 | $2,147,000 | -5.4% | 142,259 | -4.5% | 0.00% | +100.0% |
Q3 2016 | $2,270,000 | -61.3% | 148,931 | -1.5% | 0.00% | -80.0% |
Q2 2016 | $5,872,000 | +68.3% | 151,266 | +20.5% | 0.01% | +66.7% |
Q1 2016 | $3,489,000 | -41.2% | 125,515 | +13.8% | 0.00% | -25.0% |
Q4 2015 | $5,931,000 | +68.4% | 110,270 | +25.3% | 0.00% | +33.3% |
Q3 2015 | $3,523,000 | +16.7% | 87,986 | -6.9% | 0.00% | +50.0% |
Q2 2015 | $3,020,000 | +96.1% | 94,514 | +46.6% | 0.00% | +100.0% |
Q1 2015 | $1,540,000 | +31.2% | 64,489 | -3.1% | 0.00% | 0.0% |
Q4 2014 | $1,174,000 | +32.4% | 66,522 | +2.8% | 0.00% | 0.0% |
Q3 2014 | $887,000 | -18.7% | 64,725 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $1,091,000 | – | 64,725 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |